TIDMING
RNS Number : 9412D
Ingenta PLC
25 October 2022
Ingenta plc
("Ingenta" or the "Company")
Proposed Tender Offer to purchase up to 1,796,484 Ordinary
Shares at a Tender Price of 115 pence per Ordinary Share and Notice
of General Meeting
Ingenta plc ("Ingenta" or the "Company"), a leading provider of
software and services to the global publishing industry, announces
that a circular (the "Circular") will be sent to Shareholders later
today detailing a Tender Offer for up to a maximum of 1,796,484
Ordinary Shares representing approximately 11 per cent. of the
Company's issued Ordinary Shares (excluding Ordinary Shares held in
treasury) at the Tender Price of 115 pence per Ordinary Share.
Unless otherwise stated, terms used in this announcement have
the same meanings as given to them in the Circular.
The Circular sets out the terms of the Tender Offer and
incorporates a notice of a General Meeting to be held at 10.00 a.m.
on 11 November 2022 at Suite 2, Whichford House, Parkway Court,
John Smith Drive, Oxford, OX4 2JY. A Tender Form for use by
Shareholders who hold their Ordinary Shares in certificated form in
connection with the Tender Offer is also being despatched with the
Circular.
The information communicated in this announcement contains
inside information for the purposes of Article 7 of the UK version
of the EU Market Abuse Regulation (2014/596) which is part of UK
law by virtue of the European Union (Withdrawal) Act 2018, as
amended and supplemented from time to time.
For further information please contact:
Ingenta plc Tel: 01865 397 800
Scott Winner / Jon Sheffield
Cenkos Securities plc Tel: 0207 397 8900
Katy Birkin / Callum Davidson
1 Introduction
The Board announces that the Company intends to return up to
approximately GBP2.07 million of cash to Qualifying Shareholders by
way of the Tender Offer and the subsequent repurchase from Cenkos
of the Ordinary Shares successfully tendered. The Tender Offer will
be conducted at a fixed price of 115 pence per Ordinary Share (the
"Tender Price"), which represents a discount of approximately 2.13
per cent. to the middle market closing price of an Ordinary Share
on 24 October 2022 (being the Latest Practicable Date) and will be
subject to the passing of a resolution by Shareholders as set out
in the General Meeting in Part V of the Circular.
If the maximum number of Ordinary Shares under the Tender Offer
is acquired, this would result in the purchase of approximately 11
per cent. of the Company's current issued share capital (excluding
Ordinary Shares held in treasury).
The Company is seeking authority to buy back up to approximately
1,796,484 Ordinary Shares pursuant to the Resolution to be put
before Shareholders at the General Meeting.
This is not a recommendation to Shareholders to sell or tender
their Ordinary Shares. Shareholders are not obliged to tender any
Ordinary Shares and Shareholders who wish to retain all of their
investment in the Company should not return a Tender Form or submit
a TTE Instruction. Whether or not Qualifying Shareholders tender
any Ordinary Shares will depend on, among other things, their view
of the Company's prospects and their own individual circumstances,
including their tax position, on which they should seek their own
independent advice.
2 Background to and reasons for the Tender Offer
The Board continually reviews the Company's capital allocation
to maximise long-term returns to Shareholders. Since the Company's
admission to trading on AIM in 2007, the Board has sought to return
value to Shareholders through a combination of capital
appreciation, share buybacks and dividend payments.
Over the past three years, the Company has demonstrated a
resilient trading performance despite the impact of the COVID-19
pandemic. Through careful management of the Group's cost base, the
Company continued to enhance operating performance, leading to 2021
KPIs exceeding those achieved prior to the COVID-19 pandemic. This
enhancement has continued into 2022. From FY 2019 to FY 2021,
annualised recurring revenue grew from GBP8.4 million to GBP8.9
million, adjusted EBITDA increased from GBP1.3 million to GBP1.5
million and net loss after tax of GBP1.4 million recovered to net
profit of GBP1.8 million. Since 2019, the Company has returned over
GBP1.63 million to Shareholders by way of dividend payments and
share buybacks.
On 21 September 2022, the Company published its interim results
for the six-month period ended 30 June 2022 ("Interim Results"),
reporting an increase in margins and resultant profitability
alongside a return to revenue growth, benefitting from the
continued expansion in the Group's Managed Service offering and a
small number of non-recurring items. The Company has continued to
be strongly cash generative and, following net cash generation of
GBP1.4 million for the half year, had a healthy balance sheet with
closing cash balances of GBP4.4 million as at 30 June 2022.
Whilst the Board continues to explore further growth
opportunities, it currently considers that, following continued
strong cash generation which is expected to continue through FY
2022 and beyond, the Company has a level of cash on its balance
sheet that is surplus to its short-term requirements.
Taking account of the Group's working capital requirements, the
funding of the potential future growth of the business and to
ensure the Company's ability to maintain a progressive dividend,
the Board has estimated the surplus cash in the business to be
approximately GBP2.07 million.
The Board considers that the Tender Offer would be the most
suitable way of returning capital to Shareholders in a quick and
efficient manner, taking into account the relative costs,
complexity and timeframes of other possible methods, as well as the
likely tax treatment for and equality of treatment of Shareholders.
Accordingly, the Board has resolved, subject to the passing of the
Resolution, to seek to return up to approximately GBP2.07 million
to Qualifying Shareholders under the Tender Offer.
3 Benefits of the Tender Offer
The benefits of the Tender Offer, compared to other available
options for a return of surplus cash to Shareholders, are that the
Tender Offer:
-- provides all Qualifying Shareholders who wish to sell
Ordinary Shares with the opportunity to do so;
-- allows the Company to broaden the return of cash to include
those Qualifying Shareholders whose Ordinary Shares might not
otherwise be purchased by the Company through a buy-back in the
market;
-- enables Qualifying Shareholders to decide whether to tender
none, some or all of their Ordinary Shares within the overall
limits of the Tender Offer;
-- enables those Qualifying Shareholders who do not wish to
receive capital at this time to maintain their full investment in
the Company;
-- enables Ordinary Shares to be sold free of commissions or
charges that would otherwise be payable if Qualifying Shareholders
were to sell their Ordinary Shares through their broker; and
-- enhances earnings per share in respect of Ordinary Shares and
the percentage holdings of Ordinary Shares of Shareholders not
tendered under the Tender Offer.
4 The Tender Offer
Structure of the Tender Offer
The Tender Offer will be implemented on the basis of Cenkos
acquiring, as principal, the successfully tendered Ordinary Shares
at the Tender Price. The Company will purchase such Ordinary Shares
from Cenkos at the same price under the Repurchase Agreement. The
Company will cancel the Ordinary Shares purchased by it under the
Repurchase Agreement.
Up to 1,796,484 Ordinary Shares will be purchased under the
Tender Offer, representing approximately 11 per cent. of the
Company's issued share capital (excluding Ordinary Shares held in
treasury) as at 24 October 2022, being the Latest Practicable Date,
for a maximum aggregate consideration of approximately GBP2.07
million.
The Tender Offer is conditional, among other things, on the
passing of the Resolution at the General Meeting and the conditions
set out in paragraph 2.1 of Part III of the Circular.
Qualifying Shareholders can decide whether they want to tender
all, some or none of their Ordinary Shares in the Tender Offer
although Shareholders should note that applications in excess of
their Basic Entitlement may be subject to scaling-back as explained
below.
The Tender Offer is being made available to all Qualifying
Shareholders on the Register at 6.00 p.m. on the Record Date.
The Tender Offer will close at 1.00 p.m. (UK time) on 11
November 2022 and tenders received after that time will not be
accepted (unless the Tender Offer is extended).
The Tender Price
A Tender Price of 115 pence per Ordinary Share will be applied
to all Ordinary Shares purchased by Cenkos pursuant to the Tender
Offer.
The Tender Price will allow Cenkos to purchase the maximum
number of Ordinary Shares for a total cost not exceeding
approximately GBP2.07 million or, if the aggregate price of all
Ordinary Shares validly tendered by Qualifying Shareholders is less
than approximately GBP2.07 million, all of the Ordinary Shares
validly tendered pursuant to the Tender Offer.
Number of Ordinary Shares to be purchased and scaling-back
Under the Tender Offer, each QualifyingShareholder is entitled
to tender up to 11 per cent. of its, his or her shareholding to be
purchased by Cenkos at the Tender Price (being their Basic
Entitlement). Each Qualifying Shareholder's Basic Entitlement will
be calculated by the Registrars as at the Record Date by reference
to the Qualifying Shareholder's holding of Ordinary Shares as at
that date.
In addition, QualifyingShareholders are entitled to make an
application to tender in excess of their Basic Entitlements. The
extent to which excess applications can be accepted will depend on
the number of Ordinary Shares tendered by other Qualifying
Shareholders.
Provided that the conditions in paragraph 2.1 of Part III of the
Circular are met, if the aggregate value at the Tender Price of all
validly tendered Ordinary Shares is less than approximately GBP2.07
million, then all Ordinary Shares validly tendered (including
applications in excess of Basic Entitlements) will be purchased at
the Tender Price.
If the number of Ordinary Shares validly tendered by Qualifying
Shareholders is more than approximately GBP2.07 million, tenders
will be accepted in the order set out below:
a) all Ordinary Shares tendered by Qualifying Shareholders up to
their Basic Entitlement will be accepted in full; and
b) tenders of Ordinary Shares in excess of the Qualifying
Shareholders' Basic Entitlements will be satisfied pro rata in
proportion to the amount tendered in excess of Basic Entitlements
(rounded down to the nearest whole number of Ordinary Shares) or
otherwise at the discretion of the Board, in agreement with
Cenkos.
For the avoidance of doubt, the number of Ordinary Shares to be
purchased in the Tender Offer will not, in any event, exceed
1,796,484 Ordinary Shares.
Once lodged (in the case of a Tender Form) or settled (in the
case of a TTE Instruction) such tender shall be irrevocable.
Ordinary Shares will be purchased pursuant to the Tender Offer
on or around 14 November 2022.
Successfully tendered Ordinary Shares will be purchased free of
commission and dealing charges.
Any Ordinary Shares repurchased by the Company from Cenkos
following the purchase by Cenkos will be cancelled. Any rights of
Ordinary Shareholders who do not tender their Ordinary Shares will
be unaffected.
Subject to any applicable rules and regulations, the Company
reserves the right at any time prior to the announcement of the
results of the Tender Offer, and with the prior consent of Cenkos,
to extend the period during which the Tender Offer is open, based
on market conditions and/or other factors.
Basic Entitlement
Ordinary Shares tendered under the Tender Offer in respect of up
to 11 per cent. of each registered holding of Ordinary Shares of
every Qualifying Shareholder on the Record Date will be accepted in
full at the Tender Price and will not be scaled down, provided that
such Ordinary Shares are validly tendered. This percentage is known
as the "Basic Entitlement".
Qualifying Shareholders may tender Ordinary Shares in excess of
their Basic Entitlement. However, if the Tender Offer is
oversubscribed, the tender of such excess Ordinary Shares will only
be successful to the extent that other QualifyingShareholders have
tendered less than their Basic Entitlement and may be subject to
the scaling-back arrangements described above.
Circumstances in which the Tender Offer may not proceed
The Tender Offer is conditional on the passing of the Resolution
at the General Meeting and the other conditions specified in
paragraph 2.1 of Part III of the Circular.
The Tender Offer is also conditional on no material adverse
change or certain other force majeure events arising prior to the
closing of the Tender Offer. Further details of these conditions
are set out in paragraph 2.1 of Part III of the Circular.
Full terms and conditions of the Tender Offer are set out in
Part III of the Circular, which Shareholders are recommended to
read in full.
5 Authority to make market purchases of own shares
The Notice of General Meeting sets out the Resolution to
authorise the Company to buy back up to a maximum of 11 per cent.
of the issued share capital of the Company (excluding Ordinary
Shares held in treasury) representing approximately 1,796,484
Ordinary Shares pursuant to (and solely in relation to) the Tender
Offer.
6 Repurchase Agreement
Under the Repurchase Agreement, the parties have agreed that,
subject to, amongst other things, the sum of approximately GBP2.07
million (equal to the Tender Price multiplied by the maximum number
of Ordinary Shares that could be repurchased under the Tender
Offer) being received by Cenkos (or its custodian) by no later than
5.00 p.m. on 14 November 2022 (or such later time and/or date as
may be agreed by Cenkos and the Company) and the Tender Offer
becoming unconditional in all respects and not lapsing or
terminating in accordance with its terms, Cenkos shall, as
principal, purchase, "on exchange", at the Tender Price, Ordinary
Shares successfully tendered to it, up to a maximum aggregate
value, at the Tender Price, of approximately GBP2.07 million.
The Company has agreed that, immediately following the purchase
by Cenkos of all Ordinary Shares which it has agreed to purchase as
principal under the terms of the Tender Offer, the Company will
purchase from Cenkos all such Ordinary Shares at a price per
Ordinary Share equal to the Tender Price. All transactions will be
carried out on the London Stock Exchange.
Under the Repurchase Agreement, the Company has agreed to cancel
any Ordinary Shares purchased by it under the Tender Offer.
The Repurchase Agreement contains certain warranties from Cenkos
in favour of the Company concerning its authority to enter into the
Repurchase Agreement and to make the purchase of Ordinary Shares
pursuant thereto.
The Repurchase Agreement also contains warranties and
undertakings from the Company in favour of Cenkos and incorporates
an indemnity in favour of Cenkos in respect of any liability which
it may suffer in relation to the performance of its obligations
under the Tender Offer.
7 Dividends
Successfully tendered Ordinary Shares will be cancelled and will
not rank for any future dividends. However, the right of
Shareholders, recorded on the Register on 7 October 2022, to
receive and be paid the interim dividend declared in the Interim
Results released on 21 September 2022 and to be paid on 4 November
2022, will not be affected by acceptance of the Tender Offer.
8 Overseas Shareholders
The attention of Qualifying Shareholders who are citizens,
residents or nationals of countries outside the UK wishing to
participate in the Tender Offer is drawn to paragraph 6 (entitled
"Overseas Shareholders") in Part III of the Circular.
9 Taxation
Qualifying Shareholders should be aware that there may be tax
considerations that they should take into account when deciding
whether or not and/or the extent to which to participate in the
Tender Offer. A summary of the taxation consequences of the Tender
Offer for UK resident Shareholders is set out in Part IV of the
Circular. It should be noted that this tax summary is merely a
guide to current tax law and practice in the UK. Shareholders are
advised to consult their own professional advisers regarding their
own tax position.
10 Notification of interests
Under chapter 5.1.2 of the DTR, certain Shareholders are
required to notify the Company of the percentage of voting rights
they hold as Shareholders or through their direct or indirect
holding of financial instruments within the limits referred to in
the DTR. Following any purchase by the Company of Ordinary Shares
from Cenkos pursuant to the Repurchase Agreement, the percentage of
voting rights held by a Shareholder may change. Such a change in
the percentage of voting rights held by a Shareholder may give rise
to an obligation on the Shareholder to notify the Company as soon
as possible, but not later than two trading days, after becoming
aware or being deemed to have become aware of such change. If
Shareholders are in any doubt as to whether they should notify the
Company or as to the form of that notification, they should consult
their solicitor or other professional adviser.
11 Action to be taken
Tender Offer
The procedure for tendering Ordinary Shares depends on whether
Ordinary Shares are held in certificated form or uncertificated
form and is summarised below:
(a) Ordinary Shares held in certificated form
Qualifying Shareholders who hold Ordinary Shares in certificated
form and who wish to participate in the Tender Offer should follow
the instructions on the Tender Form provided to them and return it
to the Receiving Agent to arrive by no later than 1.00 p.m. on 11
November 2022. Qualifying Shareholders who hold their Ordinary
Shares in certificated form should also send their original share
certificate(s) in respect of the Ordinary Shares tendered with
their Tender Form.
(b) Ordinary Shares held in uncertificated form
Qualifying Shareholders who hold their Ordinary Shares in
uncertificated form (that is, in CREST) and who wish to participate
in the Tender Offer should tender electronically through CREST so
that the TTE Instruction settles no later than 1.00 p.m. on 11
November 2022.
Further details of the procedures for tendering and settlement
are set out in Part III of the Circular.
Shareholders who do not wish to participate in the Tender Offer
should not complete the Tender Form and should not make or arrange
for a TTE Instruction.
General Meeting
Whether or not you intend to attend the General Meeting in
person, you are encouraged to appoint a proxy. To be valid, a Form
of Proxy for use at the General Meeting must be completed and
returned so as to reach PXS1 Link Group at 10(th) Floor, Central
Square, 29 Wellington Street, Leeds LS1 4DL by not later than 10.00
a.m. on 9 November 2022.
Shareholders can appoint proxies electronically via
www.signalshares.com so that the instruction is received by Link
Group by not later than 10.00 a.m. on 9 November 2022. CREST
members can also appoint proxies by using the CREST electronic
proxy appointment service and transmitting a CREST Proxy
Instruction in accordance with the procedures set out in the CREST
Manual so that it is received by Link Group (under CREST
participant RA10) by not later than 10.00 a.m. on 9 November 2022.
The time of receipt will be taken to be the time from which Link
Group is able to retrieve the message by enquiry to CREST in the
manner prescribed by CREST.
If you are in any doubt as to the action you should take, you
are recommended to seek your own independent advice.
Recommendation
The Board considers the Resolution to be in the best interests
of Shareholders as a whole. Accordingly, the Board recommends that
Shareholders vote in favour of the Resolution to be proposed at the
General Meeting, as the Directors intend to do for their respective
individual beneficial holdings of, in aggregate, 9,801,084 Ordinary
Shares, representing approximately 60.01 per cent. of the Company's
issued share capital (excluding Ordinary Shares which are held in
treasury) as at the Latest Practicable Date.
12 General
Any repurchase of Ordinary Shares pursuant to the Repurchase
Agreement will be financed solely from the Company's existing cash
resources. No borrowings will be incurred by the Company in respect
of any repurchase of Ordinary Shares pursuant to the Repurchase
Agreement.
As at the Latest Practicable Date, the issued share capital of
the Company carrying voting rights was 16,331,679 Ordinary Shares
(excluding the 587,930 Ordinary Shares held in treasury by the
Company which do not carry voting rights).
Cenkos has given and has not withdrawn its consent to the
inclusion of its name in the Circular.
13 Irrevocable undertakings
The Company has received irrevocable undertakings to tender
Ordinary Shares under the Tender Offer in respect of, in aggregate,
1,020,875 Ordinary Shares, representing approximately 6.25 per
cent. of the current issued Ordinary Shares (excluding Ordinary
Shares held in treasury). These undertakings have been received in
relation to Basic Entitlements from Martyn Rose (and parties
connected to him) in respect of 510,995 Ordinary Shares and Kestrel
Partners LLP ("Kestrel") in respect of 509,880 Ordinary Shares.
Martyn Rose (and parties connected to him) have also undertaken not
to apply for any excess entitlements under the Tender Offer.
14 Related party transaction
The intentions and undertakings to participate in the Tender
Offer by Martyn Rose (and parties connected to him), Mark Rowse (as
detailed in paragraph 16 below) and Kestrel, are deemed to
constitute a related party transaction under AIM Rule 13. Both
Martyn Rose and Kestrel are Substantial Shareholders of the
Company, Martyn Rose and Mark Rowse are both directors and
Sebastian White, is a director who is deemed to hold managerial
responsibilities at Kestrel with Kestrel therefore being deemed to
be a person closely associated with him. The Independent Directors
consider that, having consulted with the Company's nominated
adviser, Cenkos, the terms of their participation in the Tender
Offer are fair and reasonable insofar as Shareholders are
concerned.
15 Directors' Interests
The interests (all of which are beneficial unless stated
otherwise) of the Directors and of persons connected with them
(within the meaning of Section 252 of the 2006 Act) in the issued
share capital of the Company (excluding Ordinary Shares held in
treasury) and the existence of which is known to, or could with
reasonable due diligence be ascertained by, any Director as at the
date of this announcement are as follows:
Name Position Number of Ordinary Percentage of
Shares issued share
capital
Martyn Rose(1) Chairman 4,645,412 28.44
----------------- ------------------- --------------
Chief Executive
Scott Winner Officer 22,000 0.13
----------------- ------------------- --------------
Chief Financial
Jon Sheffield Officer 13,872 0.08
----------------- ------------------- --------------
Non-executive
Neil Kirton Director 44,250 0.27
----------------- ------------------- --------------
Non-executive
Mark Rowse Director 440,277 2.70
----------------- ------------------- --------------
Non-executive
Sebastian White(2) Director 4,635,273 28.38
----------------- ------------------- --------------
Total 9,801,084 60.01
------------------- --------------
Notes:
(1) Mr Rose's interests comprise 2,280,269 Ordinary Shares held
personally by Mr Rose and 2,365,143 Ordinary Shares held by M C
Rose & J Sykes as Trustees of the MC Rose Settlement No 1 which
he is deemed to be interested in.
(2) As Mr White (a Non-executive Director of Ingenta) is deemed
to hold managerial responsibilities at Kestrel, Kestrel is deemed
to be a person closely associated with him.
16 Intentions of the Directors in relation to the Tender Offer
The Directors are currently interested, in aggregate, in
9,801,084 Ordinary Shares, representing approximately 60.01 per
cent. of the issued share capital of the Company (excluding
Ordinary Shares held in treasury). The Directors have indicated
(and in the case of Martyn Rose and Sebastian White (by virtue of
him being deemed to be a person closely associated with Kestrel)
have undertaken) their intention to tender their Ordinary Shares
(directly or through their connected parties) as follows:
Name Basic Entitlement Applications in excess
take-up of Basic Entitlement
(Ordinary Shares) (Ordinary Shares)
Martyn Rose 510,995 -
------------------- -----------------------
Scott Winner - -
------------------- -----------------------
Jon Sheffield - -
------------------- -----------------------
Neil Kirton - -
------------------- -----------------------
Mark Rowse 48,430 -
------------------- -----------------------
Sebastian White 509,880 4,125,393
------------------- -----------------------
Total 1,069,306 4,125,393
------------------- -----------------------
Excess tenders by Sebastian White will be subject to the
scaling-back arrangement described in paragraph 4 above.
Assuming that the maximum number of Ordinary Shares under the
Tender Offer are purchased and that the Directors' Basic
Entitlements are satisfied in full, the Directors (and persons
closed associated with them), following completion of the Tender
Offer, will be interested, in aggregate, in 8,731,778 Ordinary
Shares, representing approximately 60.07 per cent. of the issued
share capital of the Company (excluding Ordinary Shares held in
treasury).
17 Issued Ordinary Shares following the Tender Offer
Assuming that the maximum number of Ordinary Shares under the
Tender Offer are bought back by the Company and cancelled, the
Company's issued share capital (excluding Ordinary Shares held in
treasury) will be reduced by 1,796,484 Ordinary Shares to
14,535,195 Ordinary Shares. An announcement setting out the
Company's new issued share capital for the purposes of making DTR
5.1.2 notifications will be made following any purchase by the
Company of Ordinary Shares from Cenkos in relation to the Tender
Offer.
18 Further Information
Your attention is drawn to the information contained in the
Circular, including, in particular, the terms and conditions of the
Tender Offer in Part III.
19 Recommendation
The Board considers the Resolution to be in the best interests
of Shareholders as a whole. Accordingly, the Board recommends that
Shareholders vote in favour of the Resolution to be proposed at the
General Meeting, as the Directors intend to do for their respective
individual beneficial holdings of, in aggregate, 9,801,084 Ordinary
Shares, representing approximately 60.01 per cent. of the Company's
issued share capital (excluding Ordinary Shares held in treasury)
as at the Latest Practicable Date.
The Directors are making no recommendation to Qualifying
Shareholders in relation to participation in the Tender Offer
itself. Whether or not Qualifying Shareholders decide to tender
their Ordinary Shares will depend, amongst other things, on their
view of the Company's prospects and on their own individual
circumstances (including their own tax position).
EXPECTED TIMETABLE OF PRINCIPAL EVENTS
Announcement of the Tender Offer 25 October 2022
Posting of the Circular 25 October 2022
Tender Offer opens 25 October 2022
Latest time and date for receipt of CREST Proxy 10.00 a.m. on 9 November
Instructions for the General Meeting 2022
Latest time and date for receipt of Forms of 10.00 a.m. on 9 November
Proxy for the General Meeting 2022
10.00 a.m. on 11 November
General Meeting 2022
Announcement of result of General Meeting 11 November 2022
Latest time and date for receipt of Tender Forms
or for settlement of TTE Instructions in respect 1.00 p.m. on 11 November
of the Tender Offer 2022
6.00 p.m. on 11 November
Record Date for participation in the Tender Offer 2022
Announcement of the results of the Tender Offer 14 November 2022
Cheques despatched and CREST accounts credited
with proceeds in respect of successfully tendered on or before 28 November
Ordinary Shares 2022
CREST accounts credited with uncertificated Ordinary
Shares unsuccessfully tendered and despatch of
balance share certificates for unsold certificated on or before 28 November
Ordinary Shares (if applicable) 2022
Notes:
1. The above times and/or dates are indicative only and may
change. If any of the above times and/or dates change, the revised
times and/or dates will be notified by announcement through a
Regulatory Information Service.
2. All references to times in this announcement are to London
times unless otherwise stated.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TENMIBRTMTBTBBT
(END) Dow Jones Newswires
October 25, 2022 02:00 ET (06:00 GMT)
Ingenta (LSE:ING)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Ingenta (LSE:ING)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024